NCT00376038View on ClinicalTrials.gov

Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 Diabetes

PHASE1CompletedINTERVENTIONAL

Enrollment

13

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions

Type 2 Diabetes MellitusDiabetes Mellitus, Type 2

Interventions

DRUG

GSK189075 oral tablets

DRUG

metformin tablets

Trial Locations (1)

14050

GSK Investigational Site, Mexico City

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY